Immix Biopharma to use Nexcella slide presentation in investor meetings; no specifics given

Immix Biopharma, Inc.

Slide presentation of wholly-owned subsidiary Nexcella to be used in third-party meetings.
No financial or operational details from the presentation are included in the filing.
Event is a routine FD disclosure; no substantive news provided.

item 7.01 item 9.01

Immix Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-035728

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.